Cargando…
COVID-19 vaccine-Pfizer-BioNTech/methylprednisolone aceponate: Subacute cutaneous lupus erythematosus and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990611/ http://dx.doi.org/10.1007/s40278-022-12853-z |
Ejemplares similares
-
Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19
por: Khan, Farooq, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)